Member Info for Techtonic

Doubt it's a leak.. how many times has that been said every time there's a ramp!

It basically hits support and then a few ramping teams get involved and it creates its own momentum upwards.

Looks like it's Ramptastic time again (for about the 6th time)

I have a feeling that the board's Prodigal son will be back under yet another guise in the near future ..I kind of miss the madness😅.

You didn't miss much Hogbog, just the usual inane ramblings and s link to a song that I didn't understand.

He came back under the name of Redroses or something like that

Probably automatically banned with his IP number. God knows how many more devices he has to connect from ..

Joey...we await your Resurrection!

Looks like Joey's shortest life ever, Bermondsey! One morning..

A record even for the boy wonder

Oops..don't know who Ceri is! Should have read CEO's daughter

I don't really think you can draw any equivalence between two completely different companies and personnel, Vince..

But if you feel it's relevant, OBD Ceri's daughter had been on the books 2022, and the 'event' was September 2023

Hi fastfood..there's all sorts of new stage 1 tests in the formulation process at the mo (that have been in the media and spoken about on here). General feeling is that they are between three and five years away.

An educated guess would say by 10 years there will be better tests that cover more cancers than Ciz

Nice posts Green.

Fastfood...I don't think this test will be relevant in 10 years imo.

And Ciz Bio already indicated they want to sell at some point.

I think this will be private in a couple of years or so.

Thanks Green for the thoughtful and lengthy reply. I think there's some fair points in there.

But my main theme of the past being a predicator of the future..and trying to analyze that , is the main thrust of what I'm saying.

Ie: you say that the China deal is now probably obsolete, but with no reference or questioning of why or how, and criticism of what has been said.

If it is dead (as I always have stated).. my reasons for this were past dealings with China through my own shares and learning of how China behave.

So you can't just say China is dead without any further comment. You have to ask were Ciz naive, were they misled, did the deal not stack up, were China happy with the saints science etc etc. This then helps form a view of Ciz themselves.

Like with IgenomeDX. It's ok saying that's something probably didn't work out.

But then you have to take it further by asking why did Ciz lie, is lying and obfuscation in the DNA of the company? Why didn't this work out? Is the practicality of the test actually proving difficult?

Why do Ciz always mention sensitivity but never specificity? (Which we know was poor)

There are all sorts of things that can be learned by Ciz past behaviours, without simply listing them as "things that have happened".

Ahoy, good to hear from Vince and green again.

Green, I've got to say that you remind me of a friend of mine.. who sees things in an overly optimistic way and doesn't appear to learn from past statements and behaviors (that is said with a lot of respect and I think you're a good poster on here.. and likeable)

But I have to agree with Vince.

Being an ex reporter, these fluffy "interviews" really bug me. There is absolutely no critical prodding.

If you look back Allan Syms has been coming out with the same guff for an eternity. Years.

"We are now entering, we are now in a very exciting period"

"After this year , talking to groups close to the NHS/Europe.."

What groups? how was the 150k used? What do the NHS think of the test? If it's easier to license in the USA (and that is proving lengthy) what are the pathways in the NHS and Europe? Why is that not being run in parallel? How much extra funding will be needed?

Is Alan Symms really the man to take this forward?

In an RNS about a year ago he again mentioned CHINA again. Now no mention. It's BS imo. And he certainly is not the man to negotiate with China.

I'm still not convinced that this Omni Diagnostics in the US is a good fit.

Why did Ciz say in RNS march 24 that IGenomeDx what's appointed by bio as the first clinical diagnostics lab to offer commercial testing? (When it wasn't, and all it was doing was "experiment s".

How far has Omni really got with validating? Will it cut the mustard or fall through?

Thinking of telephoning them after I've sent 4 emails with no response. The only thing that stopped me was £4/min call charges!

There seems to be an owner called William Wirtz who also runs sales in Florida. Not sure if it's the same company, but Omni in Texas is mainly a sales team with a couple of poor lab reviews.

I've got a call holding at 1.5p , think it will go lower..but also not sure if it's wise to buy lower as too much BS and hot air from Ciz.

Vinc called it right imo

.

Highland.. yes I think it probably is a case of it being difficult to find a company to dedicate time to this.

Just that reading some of the remarks about Omni, doesn't exactly fill with confidence that they can fulfill the mandate from Ciz.in volume - and accuracy. We shall see. It hasn't been validated yet.

And after "validation" - if it happens, what then? Immediate launch or trials to test roll-out capability etc.

I think they either launch and then try to organically grow, albeit slowly, or they going to be waiting forever to get full Stateside infiltration.

Ps spelling mistake is when you press "Testing Modalities" button.

Hmm..a comment on a man's demeanor when he makes the public appearance is not an attack.

Anyway back to the subject again..

Omni?

(Ps thanks shins of the thin variety..I do wonder what "validating" actually means).

But let's stick to the subject of Omni Diagnostics - compared to the Texas company we expected to be doing rollout.

Thanks

So this is the major US pharmacy firm Ciz has chosen for national rollout.

They have one small office in Richardson Texas , and apparently one more new link in New York. That's it.

The several reviews I found are pretty awful.

AND ..

Just go to their homepage and read:

"YOUR TRUSTED PARTNER IN ADVANCED LABORATORY TESTING. At OMNITLEATH...(sic) We deliver reliable accurate..."

Are you joking?!! That is SHOCKING! They can't even spell the name of their own company right in the PR which is supposed to be promoting accuracy.

I find it appalling they can't even spell the name of their own company right. Speaks volumes.

Green et al.. I don't care what you think about my motives. I can tell you all I feel is massive disappointment having built up a stake. (I sold a lot yesterday but this wasn't from trading this is because I do not believe this company (Ciz ) is being straight with us..again.

This omni health looks like a small , under staffed, underfunded, and very poor (if you read what's available online).

My increasing scepticism about Ciz was turning rund to a point..like most people here, I believed they were going to pick a national big-hitter name for rollout. Feels like they're scraping around quite desperately. Probably not their fault but rather I'm guessing it's very difficult to pick a partner who has the time and resources for what Ciz need.

Just can't see how this is going to work out with major accelerated rollout.

I'm being honest that I was in here for a trade and sell out after hearing launch news. I've got a real feeling now that this isn't going to launch until late 2025 to 2026.. and then really what does "launch" mean?!.

A few thousand tests here and there scattered around parts of the US that this (non)Omni-seems to be.

Lots of long-term holders here got major blinkers on. Head in sand. Naive or just can't force themselves to say they've been wrong.

Again, I do see and uplift on launch .. but absolutely doubt that will be sustained.

And Allan Symms looks like a jaded man to me, talking of possible leads s in the next six months into UK/Europe. I'd love to know he's honest opinion of this omni health tie-up. I'm guessing he's getting too old for all of this hassle.

I would like to see other holders HONEST opinions of this Omni tie up , thanks (and please refrain from projected personal attacks on me. Play the ball please)

Sigh.

Wrong Green. I didn't sell any yesterday.

I sold some earlier today but that is on the back of what I believe is delays.

I haven't traded these for a while as I thought it was closer to news.

But i fervently believe that AS is full of BS... As you know I always have.

Are you telling me that you are really happy with this omnidiagnostics?!?

Devil's in the detail in this interview (as in everything Ciz says)

7 mins 33: "Omni (diagnostics) NOW have facilities in New York , and they are GOING to be rolling that out across 6 other States."

So this tiny approx 10-staff company , which already seems spread thin, with limited revenue.. is going to roll out.? Hmm

I'm sure a few on here are probably disappointed with this company they have chosen.

It seems very small for the task of national rollout.

Questions are: volume of lab capability? What are other lab tie-ups? Have they got the funds to roll out?

How long will this take?

For those who are long-term holders, maybe they're not concerned about being in here for several years..

But I'm guessing that's how long it's going to take.

Simply cannot see an avenue for large revenues Stateside.

13.10: "we have been working very closely with groups that have an interest in the UK... And HOPEFULLY that will LEAD.."

Shrugs shoulders a lot.

Maybe, hopefully, in the future, will lead to...

Blah blah blah.

He's like Keir Starmer, he never says anything exact, and he's full of meaningless words.

Firstly, I only saw the RNS relatively late and my initial impression was : "Oh dear, more guff"

If I have been able this morning, I would have sold a good portion of my holding.

This RNS basically backs up my thinking over the last 18 months... That this US rollout will be painfully slow with very low traction on sales.

First take Allan Syms usual guff, which green thought was positive (Green , I am continually bemused by your lack of skepticism despite listening to the same words over and over.. you must be an eternal optimist)

This is the usual AS rhubarb: "I forward to providing further updates on our partnerships as we continue to develop our global licensing strategy to make the CIZ1B biomarker test available globally."

Like the recent fundraiser - which was obviously to keep the lights on rather than expand.

Then from today's RNS:

"Omni has an active expansion programme to acquire or partner with other accredited laboratories throughout the USA including...blah blah.."

The word "active , acquire, etc"... So this is a company with less than $5million revenue (peanuts) that we believe is acquiring many labs..

And even if it is, how long is that going to take?! Is it really big enough to do this?

Really does sound like a rather little lab Ciz Bio has partnered with compared with what people expected.

I'm guessing this validation and roll out is going to be quite delayed. I'm still holding but may sell some tomorrow. I think they're struggling with this..

Roll out sounds a lot more complicated and long-winded than people believe.

All imo

I know you are forever the optimist Green (and Brondby) but I don't concur with BB's networking coinciding with launch - although I'm not putting money on it.

Right, looking at Omni Diagnostics : sounds to me like in traditional Ciz way, they've been scratching round for CLIA affiliated to take the test.

Weve had several false dawns here.. is this going to be another one?

According to what I can find. Omni Diagnostics: a small firm employing 8 people or there about.

Some of this next part is taken from Chatgpt.

Positives: CLIA certified, stable business variety of testing services.

Negatives:The single Glassdoor review: “They do not know how to run labs”

Because the lab is relatively small, there may be limitations in terms of resources (turnaround times, , speed of support, etc.).

The business revenue is modest; that doesn’t necessarily mean low quality, but it may mean they might not have as much buffer for large volumetric work or rapid scaling.

Doesn't exactly fill me with confidence - but I'm sure some of you with a more sunny disposition, will see some light there.

I don't know if it was green or lovely boy who suggested a diagnostics firm in Texas for the national rollout..

But it wasn't Omni.

Taking a look at omni's reviews...hmmm.. not impressive

Maybe Green ...but think you're putting the cart before the horse here. I don't think events will lead the science and accreditation. Even though it does sound a nice tie-up.